Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Thursday, April 9, 2015
Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS
Phase 2 IMAGO trial of SHP625 fails to meet primary endpoints in pediatric patients with ALGS
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment